First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Declares Dividend Increase – $0.13 Per Share

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) declared a dividend on Thursday, December 12th,NASDAQ Dividends reports. Shareholders of record on Friday, December 13th will be given a dividend of 0.1304 per share on Tuesday, December 31st. The ex-dividend date is Friday, December 13th. This is a boost from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13.

First Trust Nasdaq Pharmaceuticals ETF Stock Down 0.6 %

Shares of NASDAQ:FTXH traded down $0.17 on Friday, reaching $27.29. 259 shares of the company’s stock were exchanged, compared to its average volume of 5,087. First Trust Nasdaq Pharmaceuticals ETF has a fifty-two week low of $25.73 and a fifty-two week high of $29.72. The business’s 50-day moving average is $28.27 and its two-hundred day moving average is $28.21. The firm has a market capitalization of $16.37 million, a price-to-earnings ratio of 15.98 and a beta of 0.70.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.